Veterinary Drug Industry Research Report 2023
Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
Highlights
The global Veterinary Drug market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The key players of Veterinary Drug include Zoetis, Elanco, Boehringer Ingelheim, Merck, etc. The top four players of Veterinary Drug account for approximately 56% of the total market. Asia-Pacific is the largest market of Veterinary Drug accounting for about 34%, followed by Europe and North America. In terms of Type, Parasiticides is the largest segment, with a share about 28%. And in terms of Application, the largest application is Pets, followed by Cattle.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Drug.
The Veterinary Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Veterinary Drug market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Zoetis
Elanco
Boehringer Ingelheim
Merck
Virbac
Ceva
Vetoquinol
Dechra
Norbrook
Phibro
Huvepharma
Hipra
Ouro Fino Saude
CAHIC
Orion
Ringpu Biology
Nippon Zenyaku Kogyo
Farmavet-Pasteur
Product Type Insights
Global markets are presented by Veterinary Drug type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Veterinary Drug are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Veterinary Drug segment by Type
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Veterinary Drug market and what implications these may have on the industrys future. This report can help to understand the relevant market and consumer trends that are driving the Veterinary Drug market.
Veterinary Drug segment by Application
Pets
Cattle
Poultry
Swine
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Veterinary Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Veterinary Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Veterinary Drug industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Drug.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Veterinary Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Veterinary Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Veterinary Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?
Highlights
The global Veterinary Drug market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The key players of Veterinary Drug include Zoetis, Elanco, Boehringer Ingelheim, Merck, etc. The top four players of Veterinary Drug account for approximately 56% of the total market. Asia-Pacific is the largest market of Veterinary Drug accounting for about 34%, followed by Europe and North America. In terms of Type, Parasiticides is the largest segment, with a share about 28%. And in terms of Application, the largest application is Pets, followed by Cattle.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Drug.
The Veterinary Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Veterinary Drug market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Zoetis
Elanco
Boehringer Ingelheim
Merck
Virbac
Ceva
Vetoquinol
Dechra
Norbrook
Phibro
Huvepharma
Hipra
Ouro Fino Saude
CAHIC
Orion
Ringpu Biology
Nippon Zenyaku Kogyo
Farmavet-Pasteur
Product Type Insights
Global markets are presented by Veterinary Drug type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Veterinary Drug are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Veterinary Drug segment by Type
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Veterinary Drug market and what implications these may have on the industrys future. This report can help to understand the relevant market and consumer trends that are driving the Veterinary Drug market.
Veterinary Drug segment by Application
Pets
Cattle
Poultry
Swine
Others
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Veterinary Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Veterinary Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Veterinary Drug industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Drug.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Veterinary Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Veterinary Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Veterinary Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
Which product segment grabbed the largest share in the Product Name market?
How is the competitive scenario of the Product Name market?
Which are the key factors aiding the Product Name market growth?
Which are the prominent players in the Product Name market?
Which region holds the maximum share in the Product Name market?
What will be the CAGR of the Product Name market during the forecast period?
Which application segment emerged as the leading segment in the Product Name market?
What key trends are likely to emerge in the Product Name market in the coming years?
What will be the Product Name market size by 2028?
Which company held the largest share in the Product Name market?
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Veterinary Drug Market Size (2018-2029) & (US$ Million)
2.2.2 Global Veterinary Drug Sales (2018-2029)
2.2.3 Global Veterinary Drug Market Average Price (2018-2029)
2.3 Veterinary Drug by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Anti-Infectives
1.2.3 Anti-Inflammatory
1.2.4 Parasiticides
1.2.5 Analgesics
1.2.6 Sedatives
1.2.7 Others
2.4 Veterinary Drug by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Pets
2.4.3 Cattle
2.4.4 Poultry
2.4.5 Swine
2.4.6 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Veterinary Drug Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Veterinary Drug Sales (M Units) of Manufacturers (2018-2023)
3.3 Global Veterinary Drug Revenue of Manufacturers (2018-2023)
3.4 Global Veterinary Drug Average Price by Manufacturers (2018-2023)
3.5 Global Veterinary Drug Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Veterinary Drug, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Veterinary Drug, Product Type & Application
3.8 Global Manufacturers of Veterinary Drug, Date of Enter into This Industry
3.9 Global Veterinary Drug Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Zoetis
4.1.1 Zoetis Company Information
4.1.2 Zoetis Business Overview
4.1.3 Zoetis Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Zoetis Veterinary Drug Product Portfolio
4.1.5 Zoetis Recent Developments
4.2 Elanco
4.2.1 Elanco Company Information
4.2.2 Elanco Business Overview
4.2.3 Elanco Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Elanco Veterinary Drug Product Portfolio
4.2.5 Elanco Recent Developments
4.3 Boehringer Ingelheim
4.3.1 Boehringer Ingelheim Company Information
4.3.2 Boehringer Ingelheim Business Overview
4.3.3 Boehringer Ingelheim Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Boehringer Ingelheim Veterinary Drug Product Portfolio
4.3.5 Boehringer Ingelheim Recent Developments
4.4 Merck
4.4.1 Merck Company Information
4.4.2 Merck Business Overview
4.4.3 Merck Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Merck Veterinary Drug Product Portfolio
4.4.5 Merck Recent Developments
4.5 Virbac
4.5.1 Virbac Company Information
4.5.2 Virbac Business Overview
4.5.3 Virbac Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Virbac Veterinary Drug Product Portfolio
6.5.5 Virbac Recent Developments
4.6 Ceva
4.6.1 Ceva Company Information
4.6.2 Ceva Business Overview
4.6.3 Ceva Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Ceva Veterinary Drug Product Portfolio
4.6.5 Ceva Recent Developments
4.7 Vetoquinol
4.7.1 Vetoquinol Company Information
4.7.2 Vetoquinol Business Overview
4.7.3 Vetoquinol Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Vetoquinol Veterinary Drug Product Portfolio
4.7.5 Vetoquinol Recent Developments
6.8 Dechra
4.8.1 Dechra Company Information
4.8.2 Dechra Business Overview
4.8.3 Dechra Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Dechra Veterinary Drug Product Portfolio
4.8.5 Dechra Recent Developments
4.9 Norbrook
4.9.1 Norbrook Company Information
4.9.2 Norbrook Business Overview
4.9.3 Norbrook Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Norbrook Veterinary Drug Product Portfolio
4.9.5 Norbrook Recent Developments
4.10 Phibro
4.10.1 Phibro Company Information
4.10.2 Phibro Business Overview
4.10.3 Phibro Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Phibro Veterinary Drug Product Portfolio
4.10.5 Phibro Recent Developments
6.11 Huvepharma
6.11.1 Huvepharma Company Information
6.11.2 Huvepharma Veterinary Drug Business Overview
6.11.3 Huvepharma Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Huvepharma Veterinary Drug Product Portfolio
6.11.5 Huvepharma Recent Developments
6.12 Hipra
6.12.1 Hipra Company Information
6.12.2 Hipra Veterinary Drug Business Overview
6.12.3 Hipra Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Hipra Veterinary Drug Product Portfolio
6.12.5 Hipra Recent Developments
6.13 Ouro Fino Saude
6.13.1 Ouro Fino Saude Company Information
6.13.2 Ouro Fino Saude Veterinary Drug Business Overview
6.13.3 Ouro Fino Saude Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Ouro Fino Saude Veterinary Drug Product Portfolio
6.13.5 Ouro Fino Saude Recent Developments
6.14 CAHIC
6.14.1 CAHIC Company Information
6.14.2 CAHIC Veterinary Drug Business Overview
6.14.3 CAHIC Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
6.14.4 CAHIC Veterinary Drug Product Portfolio
6.14.5 CAHIC Recent Developments
6.15 Orion
6.15.1 Orion Company Information
6.15.2 Orion Veterinary Drug Business Overview
6.15.3 Orion Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Orion Veterinary Drug Product Portfolio
6.15.5 Orion Recent Developments
6.16 Ringpu Biology
6.16.1 Ringpu Biology Company Information
6.16.2 Ringpu Biology Veterinary Drug Business Overview
6.16.3 Ringpu Biology Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Ringpu Biology Veterinary Drug Product Portfolio
6.16.5 Ringpu Biology Recent Developments
6.17 Nippon Zenyaku Kogyo
6.17.1 Nippon Zenyaku Kogyo Company Information
6.17.2 Nippon Zenyaku Kogyo Veterinary Drug Business Overview
6.17.3 Nippon Zenyaku Kogyo Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Nippon Zenyaku Kogyo Veterinary Drug Product Portfolio
6.17.5 Nippon Zenyaku Kogyo Recent Developments
6.18 Farmavet-Pasteur
6.18.1 Farmavet-Pasteur Company Information
6.18.2 Farmavet-Pasteur Veterinary Drug Business Overview
6.18.3 Farmavet-Pasteur Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Farmavet-Pasteur Veterinary Drug Product Portfolio
6.18.5 Farmavet-Pasteur Recent Developments
5 Global Veterinary Drug Market Scenario by Region
5.1 Global Veterinary Drug Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Veterinary Drug Sales by Region: 2018-2029
5.2.1 Global Veterinary Drug Sales by Region: 2018-2023
5.2.2 Global Veterinary Drug Sales by Region: 2024-2029
5.3 Global Veterinary Drug Revenue by Region: 2018-2029
5.3.1 Global Veterinary Drug Revenue by Region: 2018-2023
5.3.2 Global Veterinary Drug Revenue by Region: 2024-2029
5.4 North America Veterinary Drug Market Facts & Figures by Country
5.4.1 North America Veterinary Drug Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Veterinary Drug Sales by Country (2018-2029)
5.4.3 North America Veterinary Drug Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Veterinary Drug Market Facts & Figures by Country
5.5.1 Europe Veterinary Drug Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Veterinary Drug Sales by Country (2018-2029)
5.5.3 Europe Veterinary Drug Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Veterinary Drug Market Facts & Figures by Country
5.6.1 Asia Pacific Veterinary Drug Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Veterinary Drug Sales by Country (2018-2029)
5.6.3 Asia Pacific Veterinary Drug Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Veterinary Drug Market Facts & Figures by Country
5.7.1 Latin America Veterinary Drug Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Veterinary Drug Sales by Country (2018-2029)
5.7.3 Latin America Veterinary Drug Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Veterinary Drug Market Facts & Figures by Country
5.8.1 Middle East and Africa Veterinary Drug Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Veterinary Drug Sales by Country (2018-2029)
5.8.3 Middle East and Africa Veterinary Drug Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Veterinary Drug Sales by Type (2018-2029)
6.1.1 Global Veterinary Drug Sales by Type (2018-2029) & (M Units)
6.1.2 Global Veterinary Drug Sales Market Share by Type (2018-2029)
6.2 Global Veterinary Drug Revenue by Type (2018-2029)
6.2.1 Global Veterinary Drug Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Veterinary Drug Revenue Market Share by Type (2018-2029)
6.3 Global Veterinary Drug Price by Type (2018-2029)
7 Segment by Application
7.1 Global Veterinary Drug Sales by Application (2018-2029)
7.1.1 Global Veterinary Drug Sales by Application (2018-2029) & (M Units)
7.1.2 Global Veterinary Drug Sales Market Share by Application (2018-2029)
7.2 Global Veterinary Drug Revenue by Application (2018-2029)
6.2.1 Global Veterinary Drug Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Veterinary Drug Revenue Market Share by Application (2018-2029)
7.3 Global Veterinary Drug Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Veterinary Drug Value Chain Analysis
8.1.1 Veterinary Drug Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Veterinary Drug Production Mode & Process
8.2 Veterinary Drug Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Veterinary Drug Distributors
8.2.3 Veterinary Drug Customers
9 Global Veterinary Drug Analyzing Market Dynamics
9.1 Veterinary Drug Industry Trends
9.2 Veterinary Drug Industry Drivers
9.3 Veterinary Drug Industry Opportunities and Challenges
9.4 Veterinary Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Veterinary Drug Market Size (2018-2029) & (US$ Million)
2.2.2 Global Veterinary Drug Sales (2018-2029)
2.2.3 Global Veterinary Drug Market Average Price (2018-2029)
2.3 Veterinary Drug by Type
2.3.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Anti-Infectives
1.2.3 Anti-Inflammatory
1.2.4 Parasiticides
1.2.5 Analgesics
1.2.6 Sedatives
1.2.7 Others
2.4 Veterinary Drug by Application
2.4.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.4.2 Pets
2.4.3 Cattle
2.4.4 Poultry
2.4.5 Swine
2.4.6 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Veterinary Drug Market Competitive Situation by Manufacturers (2018 Versus 2022)
3.2 Global Veterinary Drug Sales (M Units) of Manufacturers (2018-2023)
3.3 Global Veterinary Drug Revenue of Manufacturers (2018-2023)
3.4 Global Veterinary Drug Average Price by Manufacturers (2018-2023)
3.5 Global Veterinary Drug Industry Ranking, 2021 VS 2022 VS 2023
3.6 Global Manufacturers of Veterinary Drug, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Veterinary Drug, Product Type & Application
3.8 Global Manufacturers of Veterinary Drug, Date of Enter into This Industry
3.9 Global Veterinary Drug Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Zoetis
4.1.1 Zoetis Company Information
4.1.2 Zoetis Business Overview
4.1.3 Zoetis Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
4.1.4 Zoetis Veterinary Drug Product Portfolio
4.1.5 Zoetis Recent Developments
4.2 Elanco
4.2.1 Elanco Company Information
4.2.2 Elanco Business Overview
4.2.3 Elanco Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
4.2.4 Elanco Veterinary Drug Product Portfolio
4.2.5 Elanco Recent Developments
4.3 Boehringer Ingelheim
4.3.1 Boehringer Ingelheim Company Information
4.3.2 Boehringer Ingelheim Business Overview
4.3.3 Boehringer Ingelheim Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
4.3.4 Boehringer Ingelheim Veterinary Drug Product Portfolio
4.3.5 Boehringer Ingelheim Recent Developments
4.4 Merck
4.4.1 Merck Company Information
4.4.2 Merck Business Overview
4.4.3 Merck Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
4.4.4 Merck Veterinary Drug Product Portfolio
4.4.5 Merck Recent Developments
4.5 Virbac
4.5.1 Virbac Company Information
4.5.2 Virbac Business Overview
4.5.3 Virbac Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Virbac Veterinary Drug Product Portfolio
6.5.5 Virbac Recent Developments
4.6 Ceva
4.6.1 Ceva Company Information
4.6.2 Ceva Business Overview
4.6.3 Ceva Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
4.6.4 Ceva Veterinary Drug Product Portfolio
4.6.5 Ceva Recent Developments
4.7 Vetoquinol
4.7.1 Vetoquinol Company Information
4.7.2 Vetoquinol Business Overview
4.7.3 Vetoquinol Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
4.7.4 Vetoquinol Veterinary Drug Product Portfolio
4.7.5 Vetoquinol Recent Developments
6.8 Dechra
4.8.1 Dechra Company Information
4.8.2 Dechra Business Overview
4.8.3 Dechra Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
4.8.4 Dechra Veterinary Drug Product Portfolio
4.8.5 Dechra Recent Developments
4.9 Norbrook
4.9.1 Norbrook Company Information
4.9.2 Norbrook Business Overview
4.9.3 Norbrook Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
4.9.4 Norbrook Veterinary Drug Product Portfolio
4.9.5 Norbrook Recent Developments
4.10 Phibro
4.10.1 Phibro Company Information
4.10.2 Phibro Business Overview
4.10.3 Phibro Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
4.10.4 Phibro Veterinary Drug Product Portfolio
4.10.5 Phibro Recent Developments
6.11 Huvepharma
6.11.1 Huvepharma Company Information
6.11.2 Huvepharma Veterinary Drug Business Overview
6.11.3 Huvepharma Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Huvepharma Veterinary Drug Product Portfolio
6.11.5 Huvepharma Recent Developments
6.12 Hipra
6.12.1 Hipra Company Information
6.12.2 Hipra Veterinary Drug Business Overview
6.12.3 Hipra Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Hipra Veterinary Drug Product Portfolio
6.12.5 Hipra Recent Developments
6.13 Ouro Fino Saude
6.13.1 Ouro Fino Saude Company Information
6.13.2 Ouro Fino Saude Veterinary Drug Business Overview
6.13.3 Ouro Fino Saude Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Ouro Fino Saude Veterinary Drug Product Portfolio
6.13.5 Ouro Fino Saude Recent Developments
6.14 CAHIC
6.14.1 CAHIC Company Information
6.14.2 CAHIC Veterinary Drug Business Overview
6.14.3 CAHIC Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
6.14.4 CAHIC Veterinary Drug Product Portfolio
6.14.5 CAHIC Recent Developments
6.15 Orion
6.15.1 Orion Company Information
6.15.2 Orion Veterinary Drug Business Overview
6.15.3 Orion Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Orion Veterinary Drug Product Portfolio
6.15.5 Orion Recent Developments
6.16 Ringpu Biology
6.16.1 Ringpu Biology Company Information
6.16.2 Ringpu Biology Veterinary Drug Business Overview
6.16.3 Ringpu Biology Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Ringpu Biology Veterinary Drug Product Portfolio
6.16.5 Ringpu Biology Recent Developments
6.17 Nippon Zenyaku Kogyo
6.17.1 Nippon Zenyaku Kogyo Company Information
6.17.2 Nippon Zenyaku Kogyo Veterinary Drug Business Overview
6.17.3 Nippon Zenyaku Kogyo Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Nippon Zenyaku Kogyo Veterinary Drug Product Portfolio
6.17.5 Nippon Zenyaku Kogyo Recent Developments
6.18 Farmavet-Pasteur
6.18.1 Farmavet-Pasteur Company Information
6.18.2 Farmavet-Pasteur Veterinary Drug Business Overview
6.18.3 Farmavet-Pasteur Veterinary Drug Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Farmavet-Pasteur Veterinary Drug Product Portfolio
6.18.5 Farmavet-Pasteur Recent Developments
5 Global Veterinary Drug Market Scenario by Region
5.1 Global Veterinary Drug Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Veterinary Drug Sales by Region: 2018-2029
5.2.1 Global Veterinary Drug Sales by Region: 2018-2023
5.2.2 Global Veterinary Drug Sales by Region: 2024-2029
5.3 Global Veterinary Drug Revenue by Region: 2018-2029
5.3.1 Global Veterinary Drug Revenue by Region: 2018-2023
5.3.2 Global Veterinary Drug Revenue by Region: 2024-2029
5.4 North America Veterinary Drug Market Facts & Figures by Country
5.4.1 North America Veterinary Drug Market Size by Country: 2018 VS 2022 VS 2029
5.4.2 North America Veterinary Drug Sales by Country (2018-2029)
5.4.3 North America Veterinary Drug Revenue by Country (2018-2029)
5.4.4 United States
5.4.5 Canada
5.5 Europe Veterinary Drug Market Facts & Figures by Country
5.5.1 Europe Veterinary Drug Market Size by Country: 2018 VS 2022 VS 2029
5.5.2 Europe Veterinary Drug Sales by Country (2018-2029)
5.5.3 Europe Veterinary Drug Revenue by Country (2018-2029)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.6 Asia Pacific Veterinary Drug Market Facts & Figures by Country
5.6.1 Asia Pacific Veterinary Drug Market Size by Country: 2018 VS 2022 VS 2029
5.6.2 Asia Pacific Veterinary Drug Sales by Country (2018-2029)
5.6.3 Asia Pacific Veterinary Drug Revenue by Country (2018-2029)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Indonesia
5.6.11 Thailand
5.6.12 Malaysia
5.7 Latin America Veterinary Drug Market Facts & Figures by Country
5.7.1 Latin America Veterinary Drug Market Size by Country: 2018 VS 2022 VS 2029
5.7.2 Latin America Veterinary Drug Sales by Country (2018-2029)
5.7.3 Latin America Veterinary Drug Revenue by Country (2018-2029)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Veterinary Drug Market Facts & Figures by Country
5.8.1 Middle East and Africa Veterinary Drug Market Size by Country: 2018 VS 2022 VS 2029
5.8.2 Middle East and Africa Veterinary Drug Sales by Country (2018-2029)
5.8.3 Middle East and Africa Veterinary Drug Revenue by Country (2018-2029)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Veterinary Drug Sales by Type (2018-2029)
6.1.1 Global Veterinary Drug Sales by Type (2018-2029) & (M Units)
6.1.2 Global Veterinary Drug Sales Market Share by Type (2018-2029)
6.2 Global Veterinary Drug Revenue by Type (2018-2029)
6.2.1 Global Veterinary Drug Sales by Type (2018-2029) & (US$ Million)
6.2.2 Global Veterinary Drug Revenue Market Share by Type (2018-2029)
6.3 Global Veterinary Drug Price by Type (2018-2029)
7 Segment by Application
7.1 Global Veterinary Drug Sales by Application (2018-2029)
7.1.1 Global Veterinary Drug Sales by Application (2018-2029) & (M Units)
7.1.2 Global Veterinary Drug Sales Market Share by Application (2018-2029)
7.2 Global Veterinary Drug Revenue by Application (2018-2029)
6.2.1 Global Veterinary Drug Sales by Application (2018-2029) & (US$ Million)
6.2.2 Global Veterinary Drug Revenue Market Share by Application (2018-2029)
7.3 Global Veterinary Drug Price by Application (2018-2029)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Veterinary Drug Value Chain Analysis
8.1.1 Veterinary Drug Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Veterinary Drug Production Mode & Process
8.2 Veterinary Drug Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Veterinary Drug Distributors
8.2.3 Veterinary Drug Customers
9 Global Veterinary Drug Analyzing Market Dynamics
9.1 Veterinary Drug Industry Trends
9.2 Veterinary Drug Industry Drivers
9.3 Veterinary Drug Industry Opportunities and Challenges
9.4 Veterinary Drug Industry Restraints
10 Report Conclusion
11 Disclaimer